JP2016521708A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016521708A5 JP2016521708A5 JP2016517971A JP2016517971A JP2016521708A5 JP 2016521708 A5 JP2016521708 A5 JP 2016521708A5 JP 2016517971 A JP2016517971 A JP 2016517971A JP 2016517971 A JP2016517971 A JP 2016517971A JP 2016521708 A5 JP2016521708 A5 JP 2016521708A5
- Authority
- JP
- Japan
- Prior art keywords
- ac6mut
- nucleic acid
- gene
- vector
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361832759P | 2013-06-07 | 2013-06-07 | |
| US61/832,759 | 2013-06-07 | ||
| PCT/US2014/040948 WO2014197624A1 (en) | 2013-06-07 | 2014-06-04 | Cycle adenosine monophosphate-incompetent adenylyl cyclase and compositions and methods for treating heart failure and increasing cardiac function |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016521708A JP2016521708A (ja) | 2016-07-25 |
| JP2016521708A5 true JP2016521708A5 (https=) | 2017-07-20 |
| JP6571069B2 JP6571069B2 (ja) | 2019-09-04 |
Family
ID=52008569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016517971A Active JP6571069B2 (ja) | 2013-06-07 | 2014-06-04 | 環状アデノシン一リン酸−インコンピテントアデニリルシクラーゼならびに心不全を処置するおよび心機能を増大させるための組成物および方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11040091B2 (https=) |
| EP (1) | EP3004343B1 (https=) |
| JP (1) | JP6571069B2 (https=) |
| KR (1) | KR20160032090A (https=) |
| CN (1) | CN105452458A (https=) |
| AU (1) | AU2014274902B2 (https=) |
| BR (1) | BR112015030355A8 (https=) |
| CA (1) | CA2914029A1 (https=) |
| DK (1) | DK3004343T3 (https=) |
| HK (1) | HK1222884A1 (https=) |
| IL (1) | IL242885B (https=) |
| RU (1) | RU2015155831A (https=) |
| WO (1) | WO2014197624A1 (https=) |
| ZA (1) | ZA201508942B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016164920A1 (en) * | 2015-04-09 | 2016-10-13 | Cornell University | Gene therapy to prevent reactions to allergens |
| EP3530278A4 (en) * | 2016-10-24 | 2019-10-30 | Gwangju Institute of Science and Technology | COMPOSITION WITH PROTEIN-PHOSPHATASE-1-INHIBITING PEPTIDE FOR THE TREATMENT OF VASCULAR DISEASES |
| WO2018090036A1 (en) * | 2016-11-14 | 2018-05-17 | Renova Therapeutics, Inc. | Method of protection for cardiac tissue |
| US11760987B2 (en) | 2017-09-07 | 2023-09-19 | The Regents Of The University Of California | Compositions and methods for the treatment or prevention of heart failure |
| EP3689363A4 (en) * | 2017-09-29 | 2021-05-19 | BethphaGen Inc. | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF CARDIAC ARRHYTHMIA |
| US20210260215A1 (en) * | 2018-06-08 | 2021-08-26 | University Of Florida Research Foundation, Incorporated | Aav cardiac gene therapy for cardiomyopathy |
| CN109010799B (zh) * | 2018-07-09 | 2021-07-06 | 沣潮医药科技（上海）有限公司 | RyR2蛋白或RyR2重组蛋白在制备抗心力衰竭药物中的用途 |
| CN109191052B (zh) * | 2018-10-22 | 2020-09-25 | 山东大学 | 一种多车型车辆路径优化方法、服务器及系统 |
| CN116234917A (zh) | 2020-07-27 | 2023-06-06 | 安杰瑞姆生物科学公司 | Dna分子组合物及其制备方法和使用方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2395839A1 (en) | 1999-12-27 | 2001-07-05 | The Regents Of The University Of California | Gene therapy for congestive heart failure |
-
2014
- 2014-06-04 CN CN201480044190.5A patent/CN105452458A/zh active Pending
- 2014-06-04 EP EP14808138.3A patent/EP3004343B1/en active Active
- 2014-06-04 US US14/893,905 patent/US11040091B2/en active Active
- 2014-06-04 WO PCT/US2014/040948 patent/WO2014197624A1/en not_active Ceased
- 2014-06-04 HK HK16111093.5A patent/HK1222884A1/zh unknown
- 2014-06-04 AU AU2014274902A patent/AU2014274902B2/en active Active
- 2014-06-04 DK DK14808138.3T patent/DK3004343T3/en active
- 2014-06-04 BR BR112015030355A patent/BR112015030355A8/pt not_active Application Discontinuation
- 2014-06-04 JP JP2016517971A patent/JP6571069B2/ja active Active
- 2014-06-04 KR KR1020167000315A patent/KR20160032090A/ko not_active Ceased
- 2014-06-04 RU RU2015155831A patent/RU2015155831A/ru not_active Application Discontinuation
- 2014-06-04 CA CA2914029A patent/CA2914029A1/en not_active Abandoned
-
2015
- 2015-12-02 IL IL242885A patent/IL242885B/en active IP Right Grant
- 2015-12-08 ZA ZA2015/08942A patent/ZA201508942B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016521708A5 (https=) | ||
| RU2015155831A (ru) | Аденилатциклаза, некомпетентная по циклическому аденозин монофосфату, композиция и способы для лечения сердечной недостаточности и улучшения сердечной функции | |
| Rufaihah et al. | Dual delivery of VEGF and ANG-1 in ischemic hearts using an injectable hydrogel | |
| JP2015508760A5 (https=) | ||
| Kim et al. | The enhancement of mature vessel formation and cardiac function in infarcted hearts using dual growth factor delivery with self-assembling peptides | |
| Rincon et al. | Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation | |
| RU2642605C2 (ru) | Системная доставка и регулируемая экспрессия паракринных генов для лечения сердечно-сосудистых и иных заболеваний | |
| Iso et al. | Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment | |
| O'Neill et al. | Biomaterial‐enhanced cell and drug delivery: lessons learned in the cardiac field and future perspectives | |
| ES2735334T3 (es) | Señalización de complejo de hippo y distrofina en la renovación de cardiomiocitos | |
| CN110494154B (zh) | 心肌病、陈旧性心肌梗塞及慢性心力衰竭的治疗剂 | |
| US20130236433A1 (en) | Methods, compositions, cells, and kits for treating ischemic injury | |
| CN114206351A (zh) | 用于人中心肌病的aav心脏基因治疗 | |
| Goldspink et al. | Growth factors, muscle function and doping | |
| Johnston et al. | Genetic correction strategies for Duchenne muscular dystrophy and their impact on the heart | |
| EA009390B1 (ru) | Плазмида, кодирующая фактор роста фибробластов, для лечения ангиогенных дефектов, ассоциированных с гиперхолестеринемией или диабетом | |
| Luo et al. | Targeted engineered exosomes alleviate myocardial infarction injury by enhancing angiogenesis and improving mitochondrial function | |
| Liu et al. | Harnessing cell reprogramming for cardiac biological pacing | |
| ES2743426T3 (es) | Proteína para inducir el crecimiento de vasos sanguíneos y usos de esta | |
| JP2025523953A (ja) | 肢帯型筋ジストロフィーのためのａｕｆ１遺伝子療法 | |
| JP2018512874A5 (https=) | ||
| Katz et al. | Gene and protein-based therapies for improving cardiac performance and regeneration | |
| Escobar et al. | CRISPR-Cas-based activation of PPARGC1A boosts endogenous mitochondria and enhances cardiac function after myocardial infarction | |
| WO2015153357A1 (en) | Compositions and methods for improving cardiac function | |
| CN111138549A (zh) | 一种抗肌萎缩融合蛋白mUp113 |